Pfizer (PFE) Stock Gains to $27.19 as Next-Gen Vaccine Trial Hits Key Milestone
Pfizer shares pushed modestly higher in midday trading, with PFE at $27.19, up $0.03 or 0.13%, even as the broader healthcare sector slipped and the S&P 500 traded lower. The…







